|
|
|
|
|
by ipaddr
1637 days ago
|
|
The first long term studies are due in 2024. You didn't expect them to be ready yet? The trials are ongoing now with large groups testing 3 doses. Some leading edge countries have moved to 4 doses. The data will be available/peered reviewed. |
|